Trade ESPR anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Esperion Therapeutics Inc (ESPR) is trading at US$3.18, up 0.00% today as of Aug 27, 16:00 EDT. The company has a market capitalisation of US$819.46M. Over the past 52 weeks, ESPR has traded between US$1.80 and US$4.18. On Syfe you can trade ESPR with $0 commission and add it to your watchlist.
| Previous close | US$3.18 |
|---|---|
| Market cap | US$819.46M |
| P/E ratio | 25.31 |
| 52-week range | US$1.80 – US$4.18 |
| Volume | 59.09M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Esperion Therapeutics Inc
Esperion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.
Year: 2013
Needham Downgrades Esperion Therapeutics to Hold From Buy
May 5, 11:08 AM · MT Newswires
Piper Sandler Downgrades Esperion Therapeutics to Neutral From Overweight, Adjusts Price Target to $3.16 From $9
May 4, 11:25 AM · MT Newswires
Jefferies Downgrades Esperion Therapeutics to Hold From Buy, Adjusts Price Target to $3.28 From $5
May 4, 11:21 AM · MT Newswires
Esperion Therapeutics, Athyrium Capital Management Sign $50 Million Japan Royalty Financing
Apr 2, 8:44 PM · MT Newswires
Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics
Apr 2, 8:33 PM · MT Newswires
Esperion Therapeutics Inc (ESPR) stock is trading at US$3.18, 0.00% from the previous close of US$3.18.
The market cap for Esperion Therapeutics Inc (ESPR) stock is approximately US$819.46M.
The price-to-earnings ratio for Esperion Therapeutics Inc (ESPR) is 25.31, based on the latest reported earnings.
The 52-week high for Esperion Therapeutics Inc (ESPR) stock is US$4.18.
The 52-week low for Esperion Therapeutics Inc (ESPR) stock is US$1.80.
Esperion Therapeutics Inc (ESPR) does not currently pay a dividend.
Stay on top of ESPR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
